SCHEMBL22240976

SCHEMBL22240976

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cc(-c5ccc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)cc5)ccc34)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.44
KDM4E B2RXH2 1/20 0.44
ATM Q13315 1/20 0.44
PTGER4 P35408 1/20 0.39
TSPO P30536 1/20 0.36
AVPR1A P37288 1/20 0.34
PRKDC P78527 1/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
NPY5R Q15761 1/20 0.34
KMT2A Q03164 3/20 0.33
PGR P06401 1/20 0.33
IL1R1 P14778 1/20 0.33
HDAC4 P56524 1/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
PLA2G2A P14555 1/20 0.33
PLA2G4A P47712 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24231136 1.00 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL22240983 0.99 L3MBTL1 (0.43) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL22023470 0.99 L3MBTL1 (0.45) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL21913910 0.99 L3MBTL1 (0.45) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL21192085 0.98 ATM (0.42) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24216232 0.98 KDM4E (0.42) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL22240717 0.98 L3MBTL1 (0.41) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL22257946 0.98 L3MBTL1 (0.41) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24215928 0.96 L3MBTL1 (0.41) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24264045 0.96 L3MBTL1 (0.41) L3MBTL1KDM4EATMPTGER4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257586-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-10-11 EP disclosed
US-20230150987-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20230150987-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-11515484-B2 Heterocyclic compound and organic light emitting element comprising same LT MATERIALS CO., LTD. (KR) 2022-11-29 US disclosed
US-20200266355-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME HEESUNG MATERIAL LTD. (KR) 2020-08-20 US disclosed
US-20200231578-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-23 US disclosed
EP-3683217-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LT Materials Co., Ltd. (KR) 2020-07-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11515484-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, CYP1A1 L3MBTL1 1142/4885KDM4E 2341/4885ATM 2995/4885
US-20230150987-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO2A1, SLCO1B3 L3MBTL1 3258/4885KDM4E 3745/4885ATM 4632/4885
US-20200266355-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, CYP1A1 L3MBTL1 1142/4885KDM4E 2341/4885ATM 2995/4885
US-20200231578-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO2A1, SLCO1B3 L3MBTL1 3258/4885KDM4E 3745/4885ATM 4632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.